癌变·畸变·突变
癌變·畸變·突變
암변·기변·돌변
CARCINOGENSES,TERATOGENSIS AND MUTAGENESIS
2014年
3期
161-164
,共4页
付艳云%张艳秋%马书梅%尹立红%浦跃朴%梁戈玉
付豔雲%張豔鞦%馬書梅%尹立紅%浦躍樸%樑戈玉
부염운%장염추%마서매%윤립홍%포약박%량과옥
纳米二氧化钛%NK细胞%免疫应答%细胞活性%细胞因子
納米二氧化鈦%NK細胞%免疫應答%細胞活性%細胞因子
납미이양화태%NK세포%면역응답%세포활성%세포인자
TiO2 nanoparticles%natural killer cell%immune response%cell activity%cytokines
目的:研究纳米二氧化钛(TiO2)对大鼠NK细胞活性和相关细胞因子的影响。方法:以SD大鼠为研究模对象,随机分为0.5、4和32 mg/kg 3个纳米TiO2染毒组,对照组(生理盐水)和微米TiO2染毒组(32 mg/kg)。采用支气管滴注染毒,每周2次,实验持续28 d。分别采用流式细胞仪分析外周血NK细胞数目,乳酸脱氢酶释放法检测脾脏NK细胞活性,液相芯片技术测定血清细胞因子IL-2和IFN-γ含量。结果:随着纳米TiO2染毒剂量的增加,脾脏NK细胞活性逐渐增加,高剂量组NK细胞活性与对照组和微米TiO2组相比,差别均具有统计学意义(P<0.05)。微米TiO2组与对照组相比,脾脏NK细胞活性无明显变化(P>0.05)。各剂量组外周血NK细胞数目及血清细胞因子IL-2、IFN-γ的变化,与对照组相比差别均无统计学意义(>0.05)。结论:在本实验剂量范围内,纳米TiO2可刺激机体产生免疫应答,增加脾脏NK细胞活性,但NK细胞活性及相关细胞因子的长期变化及潜在的机制仍需要进一步探讨。P
目的:研究納米二氧化鈦(TiO2)對大鼠NK細胞活性和相關細胞因子的影響。方法:以SD大鼠為研究模對象,隨機分為0.5、4和32 mg/kg 3箇納米TiO2染毒組,對照組(生理鹽水)和微米TiO2染毒組(32 mg/kg)。採用支氣管滴註染毒,每週2次,實驗持續28 d。分彆採用流式細胞儀分析外週血NK細胞數目,乳痠脫氫酶釋放法檢測脾髒NK細胞活性,液相芯片技術測定血清細胞因子IL-2和IFN-γ含量。結果:隨著納米TiO2染毒劑量的增加,脾髒NK細胞活性逐漸增加,高劑量組NK細胞活性與對照組和微米TiO2組相比,差彆均具有統計學意義(P<0.05)。微米TiO2組與對照組相比,脾髒NK細胞活性無明顯變化(P>0.05)。各劑量組外週血NK細胞數目及血清細胞因子IL-2、IFN-γ的變化,與對照組相比差彆均無統計學意義(>0.05)。結論:在本實驗劑量範圍內,納米TiO2可刺激機體產生免疫應答,增加脾髒NK細胞活性,但NK細胞活性及相關細胞因子的長期變化及潛在的機製仍需要進一步探討。P
목적:연구납미이양화태(TiO2)대대서NK세포활성화상관세포인자적영향。방법:이SD대서위연구모대상,수궤분위0.5、4화32 mg/kg 3개납미TiO2염독조,대조조(생리염수)화미미TiO2염독조(32 mg/kg)。채용지기관적주염독,매주2차,실험지속28 d。분별채용류식세포의분석외주혈NK세포수목,유산탈경매석방법검측비장NK세포활성,액상심편기술측정혈청세포인자IL-2화IFN-γ함량。결과:수착납미TiO2염독제량적증가,비장NK세포활성축점증가,고제량조NK세포활성여대조조화미미TiO2조상비,차별균구유통계학의의(P<0.05)。미미TiO2조여대조조상비,비장NK세포활성무명현변화(P>0.05)。각제량조외주혈NK세포수목급혈청세포인자IL-2、IFN-γ적변화,여대조조상비차별균무통계학의의(>0.05)。결론:재본실험제량범위내,납미TiO2가자격궤체산생면역응답,증가비장NK세포활성,단NK세포활성급상관세포인자적장기변화급잠재적궤제잉수요진일보탐토。P
OBJECTIVE:To explore the effects of titanium dioxide (TiO2) nanoparticles on Natural Killer (NK) cell activity and related cytokines in rats. METHODS:Sprague Dawley rats were randomly divided into 0.5,4 and 32 mg/kg TiO2 nanoparticles exposure groups,control group (0.9%sodium chloride solution),and TiO2 micro-sized particles exposure group (32 mg/kg). Rats were treated by intratracheal instillation of these substances in suspension twice a week,a total of 28 consecutive days. NK cell population in peripheral blood was measured by flow cytometry. NK cell killing activity in the spleen was analyzed by lactate dehydrogenase (LDH) release assay. Cytokines IL-2 and INF-γwere measured by liquid phase chips method. RESULTS:The NK cell activity increased with the rise of TiO2 exposure dose. Significant difference in NK cell activity in the spleen was found in the group exposed to 32 mg/kg TiO2 nanoparticles compared with the control group (P<0.05). No significant difference was found between control group and micro-sized TiO2 group (P>0.05). Compared with micro-sized TiO2 group,NK cell activity was found to be significantly increased in 32 mg/kg TiO2 nanoparticles exposure group (P<0.05). No significant change of NK cell populations,IL-2 or INF-γwas observed compared with control group and micro-sized group (P>0.05). CONCLUSION:TiO2 nanoparticles could trigger systemic immune responses,and enhance NK cell killing activity in the spleen in the studied dosage range. However,further research is needed to confirm the long-term changes in NK cell populations,NK cell killing activity and related cytokines,as well as the potential mechanisms.